1. Market Research
  2. > Healthcare
  3. > Blood Supply, Tissue Banking and Transplantation Market Trends
  4. > Graft Versus Host Disease (GVHD)-Pipeline Insights, 2016

Graft Versus Host Disease (GVHD)-Pipeline Insights, 2016

  • November 2016
  • -
  • Delve Insight
  • -
  • 60 pages


DelveInsight’s, “ Graft Versus Host Disease (GVHD)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Graft Versus Host Disease (GVHD). The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Graft Versus Host Disease (GVHD). DelveInsight’s Report also assesses the Graft Versus Host Disease (GVHD) therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope
- The report provides competitivepipeline landscape of Graft Versus Host Disease (GVHD)
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Graft Versus Host Disease (GVHD) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Graft Versus Host Disease (GVHD) and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Graft Versus Host Disease (GVHD)-Pipeline Insights, 2016

Illustrative Table of contents

- Graft Versus Host Disease (GVHD) Overview
- Graft Versus Host Disease (GVHD) Pipeline Therapeutics
- Graft Versus Host Disease (GVHD) Therapeutics under Development by Companies
- Graft Versus Host Disease (GVHD) Filed and Phase III Products
- Comparative Analysis
- Graft Versus Host Disease (GVHD) Phase II Products
- Comparative Analysis
- Graft Versus Host Disease (GVHD) Phase I and IND Filed Products
- Comparative Analysis
- Graft Versus Host Disease (GVHD) Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Graft Versus Host Disease (GVHD) - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Graft Versus Host Disease (GVHD) - Discontinued Products
- Graft Versus Host Disease (GVHD) - Dormant Products
- Companies Involved in Therapeutics Development for Graft Versus Host Disease (GVHD)
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Graft Versus Host Disease (GVHD), 2016
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2016
- Comparative Analysis Phase II Products, 2016
- Comparative Analysis Phase I and IND Filed Products, 2016
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016
- Drug Candidates Profiles
- Graft Versus Host Disease (GVHD) Assessment by Monotherapy Products
- Graft Versus Host Disease (GVHD) Assessment by Combination Products
- Graft Versus Host Disease (GVHD) Assessment by Route of Administration
- Graft Versus Host Disease (GVHD) Assessment by Stage and Route of Administration
- Graft Versus Host Disease (GVHD) Assessment by Molecule Type
- Graft Versus Host Disease (GVHD) Assessment by Stage and Molecule Type
- Graft Versus Host Disease (GVHD) Therapeutics - Discontinued Products
- Graft Versus Host Disease (GVHD) Therapeutics - Dormant Products
- Products under Development by Companies, 2016

List of Figures

- Number of Products under Development for Graft Versus Host Disease (GVHD), 2016
- Filed and Phase III Products, 2016
- Phase II Products, 2016
- Phase I and IND Filed Products, 2016
- Discovery and Pre-Clinical Stage Products, 2016
- Graft Versus Host Disease (GVHD) Assessment by Monotherapy Products
- Graft Versus Host Disease (GVHD) Assessment by Combination Products
- Graft Versus Host Disease (GVHD) Assessment by Route of Administration
- Graft Versus Host Disease (GVHD) Assessment by Stage and Route of Administration
- Graft Versus Host Disease (GVHD) Assessment by Molecule Type
- Graft Versus Host Disease (GVHD) Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Transplantation Diagnostics Global Market - Forecast to 2022

Transplantation Diagnostics Global Market - Forecast to 2022

  • $ 4500
  • Industry report
  • August 2016
  • by IQ4I Research & Consultancy Pvt. Ltd

Transplantation is a surgical procedure of transferring organ, tissue or cell taken from one part of the body and grafted into another area of the same individual or another individual of same species ...

Organ And Tissue Transplantation - Global Market Outlook (2016-2022)

Organ And Tissue Transplantation - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • September 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Organ and Tissue Transplantation market is estimated to be $XX billion in 2015 and is expected to reach $XX billion by 2022 growing at a CAGR of XX% from 2015-2022. ...

Organ Preservation - Global Market Outlook (2016-2022)

Organ Preservation - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Organ Preservation market is estimated at $153.93 million in 2015 and is expected to reach $274.19 million by 2022 growing at a CAGR of 8.7% from 2015 to 2022. ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.